List of Hydra Biosciences patents

Patents where

Current Assignee

Name

Hydra Biosciences

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7893260 Substituted quinazolin-4-one compounds for antagonizing TRPV3 function	Patent 7893260 was granted and assigned to Hydra Biosciences on February, 2011 by the United States Patent and Trademark Office.		Hydra Biosciences	United States Patent and Trademark Office	7893260	February 22, 2011
‌ US Patent 9359359 Substituted xanthines and methods of use thereof	Patent 9359359 was granted and assigned to Hydra Biosciences on June, 2016 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	9359359	June 7, 2016
‌ US Patent 8163761 Methods and compositions for treating disorders	Patent 8163761 was granted and assigned to Hydra Biosciences on April, 2012 by the United States Patent and Trademark Office.		Hydra Biosciences	United States Patent and Trademark Office	8163761	April 24, 2012
‌ US Patent 9486455 Compounds for modulating TRPV3 function	Patent 9486455 was granted and assigned to Hydra Biosciences on November, 2016 by the United States Patent and Trademark Office.		Hydra Biosciences	United States Patent and Trademark Office	9486455	November 8, 2016
‌ US Patent 9969736 Substituted xanthines and methods of use thereof	Patent 9969736 was granted and assigned to Hydra Biosciences on May, 2018 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	9969736	May 15, 2018
‌ US Patent 7998980 Compounds for modulating TRPV3 function	Patent 7998980 was granted and assigned to Hydra Biosciences on August, 2011 by the United States Patent and Trademark Office.		Hydra Biosciences	United States Patent and Trademark Office	7998980	August 16, 2011
‌ US Patent 8389546 Compounds for modulating TRPV3 function	Patent 8389546 was granted and assigned to Hydra Biosciences on March, 2013 by the United States Patent and Trademark Office.		Hydra Biosciences	United States Patent and Trademark Office	8389546	March 5, 2013
‌ US Patent 10399982 Substituted xanthines and methods of use thereof	Patent 10399982 was granted and assigned to Hydra Biosciences on September, 2019 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	10399982	September 3, 2019
‌ US Patent 7671061 Methods and compositions for treating pain	Patent 7671061 was granted and assigned to Hydra Biosciences on March, 2010 by the United States Patent and Trademark Office.		Hydra Biosciences	United States Patent and Trademark Office	7671061	March 2, 2010
‌ US Patent 9815838 Methods and compositions for treating pain	Patent 9815838 was granted and assigned to Hydra Biosciences on November, 2017 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	9815838	November 14, 2017
‌ US Patent 9012465 Compounds useful for treating disorders related to TRPA1	Patent 9012465 was granted and assigned to Hydra Biosciences on April, 2015 by the United States Patent and Trademark Office.		Hydra Biosciences	United States Patent and Trademark Office	9012465	April 21, 2015
‌ US Patent 8633233 Methods and compositions for treating anxiety	Patent 8633233 was granted and assigned to Hydra Biosciences on January, 2014 by the United States Patent and Trademark Office.		Hydra Biosciences	United States Patent and Trademark Office	8633233	January 21, 2014
‌ US Patent 8389529 Methods and compositions for treating asthma	Patent 8389529 was granted and assigned to Hydra Biosciences on March, 2013 by the United States Patent and Trademark Office.		Hydra Biosciences	United States Patent and Trademark Office	8389529	March 5, 2013
‌ US Patent 8178542 Methods and compositions for treating pain	Patent 8178542 was granted and assigned to Hydra Biosciences on May, 2012 by the United States Patent and Trademark Office.		Hydra Biosciences	United States Patent and Trademark Office	8178542	May 15, 2012
‌ US Patent 9006207 Compositions useful for treating disorders related to TRPA1	Patent 9006207 was granted and assigned to Hydra Biosciences on April, 2015 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	9006207	April 14, 2015
‌ US Patent 9649315 Composition useful for treating disorders related to TRPA1	Patent 9649315 was granted and assigned to Hydra Biosciences on May, 2017 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	9649315	May 16, 2017
‌ US Patent 9440973 Pyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione derivatives	Patent 9440973 was granted and assigned to Hydra Biosciences on September, 2016 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	9440973	September 13, 2016
‌ US Patent 9440972 Pyrido[2,3-d]pyrimidine-2,4(1 H,3H)-dione derivatives	Patent 9440972 was granted and assigned to Hydra Biosciences on September, 2016 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	9440972	September 13, 2016
‌ US Patent 9440983 Pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione derivatives	Patent 9440983 was granted and assigned to Hydra Biosciences on September, 2016 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	9440983	September 13, 2016
‌ US Patent 8710052 Compounds and compositions for treating chemical warfare agent-induced injuries	Patent 8710052 was granted and assigned to Hydra Biosciences on April, 2014 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	8710052	April 29, 2014
‌ US Patent 10221177 Inhibiting the transient receptor potential A1 ion channel	Patent 10221177 was granted and assigned to Hydra Biosciences on March, 2019 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	10221177	March 5, 2019
‌ US Patent 9745272 Quinazoline-2,4(1 H,3H)-dione derivatives	Patent 9745272 was granted and assigned to Hydra Biosciences on August, 2017 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	9745272	August 29, 2017
‌ US Patent 8952023 Compounds useful for treating injuries from warfare agents	Patent 8952023 was granted and assigned to Hydra Biosciences on February, 2015 by the United States Patent and Trademark Office.		Hydra Biosciences	United States Patent and Trademark Office	8952023	February 10, 2015
‌ US Patent 9732050 Modulators of sperm hypermotility and uses thereof	Patent 9732050 was granted and assigned to Hydra Biosciences on August, 2017 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	9732050	August 15, 2017
‌ US Patent 9951073 Compounds and compositions for treating chemical warfare agent-induced injuries	Patent 9951073 was granted and assigned to Hydra Biosciences on April, 2018 by the United States Patent and Trademark Office.	Hydra Biosciences	Hydra Biosciences	United States Patent and Trademark Office	9951073	April 24, 2018

Results per page:

42 results

0 selected

42 results

0 selected